The ethics of access to patented biotech research tools from universities and other research institutions
Journal article, Peer reviewed
Accepted version
Åpne
Permanent lenke
http://hdl.handle.net/11250/2590769Utgivelsesdato
2018Metadata
Vis full innførselSamlinger
Sammendrag
As universities and public research organizations increasingly partner with industry to fulfill their 'third mission' of innovation activities for economic and societal benefit, they have ethical obligations to ensure access to patented research tools, especially CRISPR–Cas9 technology.